Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03618654
Title Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University

head and neck squamous cell carcinoma


Durvalumab + Metformin


Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.